Mylan Ends Calif. Drug Price Inflation Claims For $57M
By Sindhu Sundar · February 27, 2012, 7:21 PM EST
Mylan Inc. will pay $57 million to resolve all claims by the state of California and a relator in multidistrict litigation accusing the drugmaker of reporting inflated average wholesale prices of...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login